Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

29,222 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
[Nedaplatin combined with tegafur in the treatment for advanced esophageal cancer]
Fan QX, et al. Zhonghua Zhong Liu Za Zhi 2008 - Clinical Trial. Among authors: Zhang MZ. PMID 19173998 Chinese.
Nedaplatin was given daily by intravenous infusion at a dose of 20 mg/m(2) for 2 hours and tegafur at a dose of 500 mg/m(2) for 8 hours on D1 approximately D5, every 21 days as a cycle. ...
Nedaplatin was given daily by intravenous infusion at a dose of 20 mg/m(2) for 2 hours and tegafur at a dose of 500 mg/m(2) fo …
Analysis of serum proteome profiles of non-Hodgkin lymphoma for biomarker identification
Zhang MZ, et al. J Proteomics 2009. PMID 19361584
A protein with the m/z of M10 197.91 u was expressed at a significantly higher level in the NHL group, compared to the other groups. ...And the protein with the m/z of M10 197.91 u may be a new serological biomarker for monitoring treatment response and evaluating the prognosis of patients with NHL....
A protein with the m/z of M10 197.91 u was expressed at a significantly higher level in the NHL group, compared to the other groups. …
29,222 results
Jump to page
Feedback